CTOs on the Move

Den-Mat Holdings, LLC.

www.denmat.com

 
Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.denmat.com
  • 2850 Skyway Dr
    Santa Maria, CA USA 93455-1410
  • Phone: 800.445.0345

Executives

Name Title Contact Details

Similar Companies

NP Medical Inc

NP Medical Inc is a Clinton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ascend Healthcare

Ascend Healthcare is a residential treatment facility for teens struggling with mental health and addiction issues. They provide evidence-based therapies, experiential therapies, and a unique clinical approach to help their clients. Their focus on fami...

Equip Health

Equip gives families lasting recovery from eating disorders through dedicated virtual care teams and gold-standard treatment delivered at home.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.